Skip to content
drillr.ai
Sign up

CARL

CARLSMED, INC.

US

—
Ask drillr

  • Sep 30, 2026, 13:16 UTC

    Carlsmed, Inc. appointed Richard Heppenstall as Chief Financial Officer effective September 28, 2026, with a $500,000 base salary and equity awards valued at $1,400,000 each.

  • Sep 30, 2026, 13:16 UTC

    Carlsmed, Inc. Chief Financial Officer Leo Greenstein departed effective September 25, 2026, with severance including $500,000 in cash payments and accelerated equity vesting.

  • Sep 15, 2026, 23:00 UTC

    Carlsmed, Inc. filed a patent infringement lawsuit against DeGen Medical, Inc. in the United States District Court for the District of South Carolina Florence Division, asserting infringement of eight patents and seeking injunctive relief and damages.

    Source:

  • Sep 8, 2026, 20:12 UTC

    Carlsmed, Inc. appointed Jeffrey Bertolini as Chief Operating Officer, effective September 8, 2026, with a base salary of $475,000 and a grant of 50,000 stock options.